» CRYOcheck™ Low Fibrinogen Control

HEMOSTASIS COAGULATION ROUTINE FROZEN CALIBRATORS AND CONTROLS SCREENING TEST CONTROLS

CRYOcheck™ Low Fibrinogen Control

Fresh frozen plasmas

Pathological control plasma for the quantitative determination of fibrinogen for a value around 0.9 g/L.

CRYOcheck™ Low Fibrinogen Control is a routine hemostasis control derived from a pool of citrated plasmas and adjusted to express the characteristics of hypofibrinogenemia.
It contains a small but known quantity of fibrinogen (around 0.9 g/L) determined by the Clauss method.

Access publications on the manufacturer's website

Reference	CCLF-10
Presentation	Kit
Format	80 x 1.0 mL
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format	Quote	Product sheet
CCLF-10	Kit	80 x 1.0 mL

Price list, safety data sheets and notices are accessible to our registered customers.

CRYOcheck™ Low Fibrinogen Control Certifcate of analysis

Fibrinogen is a soluble protein made by the liver.
Under the action of thrombin, fibrinogen is converted into fibrin.
In association with FXIII, calcium ions, fibrin forms a stable network which ensures coagulation.

- Flash freezing under nitrogen
- No bovine additivesNo reconstitution error
- No deterioration of plasmas linked to freeze-drying
- Plasmas verified negative for all tests required by the FDA
- Expiration date of 2 years from the date of manufacture with storage between -40 ° C and -80 ° C
- Packaging in plastic cryotubes suitable for all STA-R type microgodets

- 72h stability after thawing
- The exact value is indicated on the certificate of analysis.
- Ready to use in minutes after thawing
- Compact, color-coded boxes for easier identification in freezers
- CE Marking

- 80 cryotubes x 1 mL of frozen plasma

CRYOcheck™ Abnormal 1 Reference Control
CRYOcheck™ Abnormal 2 Reference Control
CRYOcheck™ Normal Reference Plasma
CRYOcheck™ Reference Control Normal

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION ROUTINE FROZEN CALIBRATORS AND CONTROLS SCREENING TEST CONTROLS